Precision Medicine and the Cancer Therapy Revolution: Fighting Cancer with the Immune System
May 25
9:00AM – 10:00AM
Yale Center for British Art | Room: Auditorium — 1080 Chapel Street
Dr. Roy S. Herbst '84 B.S., '84 M.S., Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital
Despite improvements in therapy, cancer remains the second leading cause of death in the US, after heart disease. For this reason, significant efforts have been made to examine the interaction between cancer and the immune system, leading to the discovery of the programmed death pathway, found to play a key role in immune evasion by cancer cells. Newly approved drugs that target these key immune regulators have revolutionized treatment for many types of cancer. Although these drugs have shown significant activity in some patients, only 15-20% of patients respond overall, so it remains critical that we better understand the biology of cancer and continue to identify predictive markers of sensitivity and resistance. The Yale Center for Immuno-oncology is working in all these areas. New concepts and approaches will be discussed with a focus on target validation and drug discovery.
Add to Calendar
2019-05-25T09:00:00
2019-05-25T10:00:00
America/New_York
Precision Medicine and the Cancer Therapy Revolution: Fighting Cancer with the Immune System
Dr. Roy S. Herbst '84 B.S., '84 M.S., Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital
Despite improvements in therapy, cancer remains the second leading cause of death in the US, after heart disease. For this reason, significant efforts have been made to examine the interaction between cancer and the immune system, leading to the discovery of the programmed death pathway, found to play a key role in immune evasion by cancer cells. Newly approved drugs that target these key immune regulators have revolutionized treatment for many types of cancer. Although these drugs have shown significant activity in some patients, only 15-20% of patients respond overall, so it remains critical that we better understand the biology of cancer and continue to identify predictive markers of sensitivity and resistance. The Yale Center for Immuno-oncology is working in all these areas. New concepts and approaches will be discussed with a focus on target validation and drug discovery.
Yale Center for British Art | Room: Auditorium — 1080 Chapel Street